Liposomal Bupivacaine in Rotator Cuff Repair
Purpose
To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter.
Condition
- Rotator Cuff Injury
Eligibility
- Eligible Ages
- Over 19 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Undergoing outpatient arthroscopic rotator cuff repair - Greater than or equal to 19 years of age at the time of surgery
Exclusion Criteria
- Planned operative fixation of the biceps tendon or acromioclavicular joint - Opioid use 6 weeks before surgery - Gabapentin use 6 weeks before surgery - History of prior shoulder surgery on the operative limb - Severe pulmonary dysfunction - Diagnosis of chronic pain, fibromyalgia or other somatosensory disorder(s) - History of radicular pain or neuropathy in the operative limb - Patients who are currently incapacitated for medical decision making
Study Design
- Phase
- Phase 4
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Liposomal bupivacaine Interscalene Block |
Interscalene block: - 10cc (133mg) liposomal bupivacaine;PLUS - 10cc 0.25% bupivacaine |
|
|
Active Comparator Ropivacaine Interscalene Catheter |
- 20cc 0.25% bupivacaine interscalene block; PLUS - Ropivacaine 0.25% interscalene catheter (6ml/hr for 48hrs) |
|
More Details
- Status
- Completed
- Sponsor
- University of Alabama at Birmingham